ELVN compared with NPCE: revenue, margins and what each company keeps, and the suppliers and customers both name

ELVNEnliven Therapeutics, Inc.

Mkt capRevenueRevenue

NPCENeuroPace Inc

Mkt capRevenueRevenue

Compare

ELVNEnliven Therapeutics, Inc.

NPCENeuroPace Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ELVN

1 of 4at or beyond implied

Reportimpliedrealized× implied

Nov 6 '26thin chain±9.8%▲+10.36%×1.06

Aug 6 '26±11.2%▲+0.95%×0.08

May 8 '26±11.1%▲+1.14%×0.10

Mar 4 '26±15.4%▲+4.28%×0.28

NPCE

0 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 12 '26±33.3%▼−3.26%×0.10

May 13 '26±15.3%▲+0.06%×0.01

= impliedELVN realized, solidNPCE realized, hatchedOne scale, both sides: full bar = 56%× = |realized| ÷ impliedSource: market data

Mar 4 '26

±32.3%

▲+0.87%

×0.03

Nov 5 '25±55.7%▲+38.09%×0.68

ELVNEnliven Therapeutics, Inc.

49.26▲+9.98%· post 49.29

Mkt cap$3.6BRevenue—Revenue—

NPCENeuroPace Inc

12.49▼−1.57%· post 12.53

ClosedNov 6 '26

Mkt cap$429.1MRevenue$23MQ2 FY26Revenue$96MFY25

Compare

ClosedNov 6 '26

ELVNEnliven Therapeutics, Inc.

NPCENeuroPace Inc

49.26▲+9.98%post 49.29

Price

12.49▼−1.57%post 12.53

$3.6B

Mkt cap

$429.1M

—

Revenue

$23MQ2 FY26

—

Revenue

$96MFY25

ELVN49.26▲+9.98%vsNPCE12.49▼−1.57%ClosedNov 6 '26